Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) ...
Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for chronic low back pain.Program ...
Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms ...
14d
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
Expanding the Clinical Value of Nociscan Beyond Surgical Decision Support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results